Haemostatic drugs for acute traumatic brain injury

[1]  R. Narayan,et al.  Progression of traumatic intracerebral hemorrhage: a prospective observational study. , 2008, Journal of neurotrauma.

[2]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[3]  Ewout Steyerberg,et al.  Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients , 2008, BMJ : British Medical Journal.

[4]  P. Mannucci,et al.  Prevention and treatment of major blood loss. , 2007, The New England journal of medicine.

[5]  Ewout W Steyerberg,et al.  Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. , 2007, Journal of neurotrauma.

[6]  R. Al-Shahi,et al.  Haemostatic drug therapies for acute primary intracerebral haemorrhage. , 2006, The Cochrane database of systematic reviews.

[7]  J. Astrup.  ["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid]. , 2006, Ugeskrift for laeger.

[8]  Peter Sandercock,et al.  Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months , 2005, The Lancet.

[9]  J. Holcomb.  Methods for improved hemorrhage control , 2004, Critical care.

[10]  J. Ghajar.  Traumatic brain injury , 2000, The Lancet.

[11]  U. Hedner.  NovoSeven® as a universal haemostatic agent , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  P. Bażowski,et al.  Surgery or conservative treatment in children with traumatic intracerebral haematoma , 1999, Child's Nervous System.

[13]  C. Greenberg,et al.  Antifibrinolytic drugs and perioperative hemostasis , 1997, American journal of hematology.

[14]  C. Ponticelli,et al.  IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN , 1987, The Lancet.

[15]  G. Remuzzi,et al.  Conjugated estrogens for the management of bleeding associated with renal failure. , 1986, The New England journal of medicine.

[16]  A. Hyder,et al.  The impact of traumatic brain injuries: a global perspective. , 2007, NeuroRehabilitation.

[17]  C R Prentice,et al.  Basis of antifibrinolytic therapy , 1980, Journal of clinical pathology. Supplement.